1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow Mixed Cellularity Classical Hodgkin Lymphoma: new trials by email Literature Review of Mixed Cellularity Classical Hodgkin Lymphoma trials Research Report on Mixed Cellularity Classical Hodgkin Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PET-Directed Therapy With Pembrolizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Classical Hodgkin Lymphoma Computed Tomography, Dacarbazine, Doxorubicin Hydrochloride - Classical Hodgkin Lymphoma, Lymphocyte-Depleted Classical Hodgkin Lymphoma | Phase 2 | Unknown | Northwestern University | 30 | 2017-11-09 | 2023-06-02 |
Hodgkin Disease (1)
Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphatic Diseases (1) · Lymphoma (1) · Lymphoproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1)
Dacarbazine (1) · Doxorubicin (1) · Fluorodeoxyglucose F18 (1) · Magnetic Resonance Spectroscopy (1) · Vinblastine (1) · pembrolizumab (1)
United States (1)
PMID 32992341, PMID 36083129, PMID 40135712
P30CA060553 (1)